Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
ATH434
DRUG
3 trials
Sponsors
Alterity Therapeutics
Conditions
Multiple System Atrophy
Phase 2
A Biomarker Study of ATH434 in Participants With MSA
Completed
NCT05864365
Alterity Therapeutics
Multiple System Atrophy
Start: 2023-05-23
End: 2025-02-26
Updated: 2025-04-01
Open-Label Access to ATH434 for Patients Who Completed Study ATH434-201 in France
Not yet recruiting
NCT07729852
Alterity Therapeutics
Multiple System Atrophy
Start: 2026-07-01
End: 2029-07-01
Target: 5
Updated: 2026-07-28
Unknown Phase
Post-Trial Access to ATH434 for Patients With Multiple System Atrophy
NCT07531433
Alterity Therapeutics
Multiple System Atrophy
Updated: 2026-04-15